Literature DB >> 8213299

Variability in subjective responses to cocaine: initial experiences of college students.

E S Davidson1, J F Finch, S Schenk.   

Abstract

Eighty psychology students were administered a short self-report questionnaire that probed their initial and most recent experiences with cocaine. Most of the subjects were relatively inexperienced with cocaine; only five had used the drug more than 40 times. Measures of Global Positive and Global Negative responses to cocaine use were obtained. There was substantial variability in the response to cocaine on both the positive and negative effects scales, although there was no relationship between the magnitude of these self-reported effects of cocaine. The initial Global Positive (but not Global Negative) scores were correlated with latency to next use of cocaine and with lifetime use of the drug, suggesting that abuse potential of the drug is related to magnitude of initial positive effect. These data suggest that studies on predisposing factors in cocaine abuse should examine the basis for the variability in initial response to cocaine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213299     DOI: 10.1016/0306-4603(93)90062-e

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  27 in total

1.  Initial locomotor sensitivity to cocaine varies widely among inbred mouse strains.

Authors:  T Wiltshire; R B Ervin; H Duan; M A Bogue; W C Zamboni; S Cook; W Chung; F Zou; L M Tarantino
Journal:  Genes Brain Behav       Date:  2015-03       Impact factor: 3.449

2.  Low dose nicotine treatment during early adolescence increases subsequent cocaine reward.

Authors:  Susan C McQuown; James D Belluzzi; Frances M Leslie
Journal:  Neurotoxicol Teratol       Date:  2006-12-14       Impact factor: 3.763

3.  Intravenous cocaine self-administration in a panel of inbred mouse strains differing in acute locomotor sensitivity to cocaine.

Authors:  Amanda J Roberts; Linzy Casal; Salvador Huitron-Resendiz; Trey Thompson; Lisa M Tarantino
Journal:  Psychopharmacology (Berl)       Date:  2018-01-29       Impact factor: 4.530

Review 4.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

5.  Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.

Authors:  Ajna Hamidovic; Emma Childs; Megan Conrad; Andrea King; Harriet de Wit
Journal:  Drug Alcohol Depend       Date:  2010-02-21       Impact factor: 4.492

6.  Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.

Authors:  Bruce H Mandt; Nancy R Zahniser
Journal:  Neuropharmacology       Date:  2009-12-04       Impact factor: 5.250

Review 7.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

8.  Cocaine is low on the value ladder of rats: possible evidence for resilience to addiction.

Authors:  Lauriane Cantin; Magalie Lenoir; Eric Augier; Nathalie Vanhille; Sarah Dubreucq; Fuschia Serre; Caroline Vouillac; Serge H Ahmed
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

9.  Estradiol replacement enhances cocaine-stimulated locomotion in female C57BL/6 mice through estrogen receptor alpha.

Authors:  Amanda E D Van Swearingen; Cristina L Sanchez; Suzanne M Frisbee; Antonia Williams; Q David Walker; Kenneth S Korach; Cynthia M Kuhn
Journal:  Neuropharmacology       Date:  2013-04-19       Impact factor: 5.250

10.  Disparate cocaine-induced locomotion as a predictor of choice behavior in rats trained in a delay-discounting task.

Authors:  Jessica J Stanis; Randi M Burns; Luke K Sherrill; Joshua M Gulley
Journal:  Drug Alcohol Depend       Date:  2008-06-09       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.